ORGO
Organogenesis Holdings Inc
Halal Rating :
Last Price
$3.35
Last updated:
Market Cap
-
7D Change
11.5%
1 Year Change
-11.27%
Company Overview
Industries
Exchange
Next Earnings Date
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacturing, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. The company's product portfolio includes advanced wound care products, surgical & sports medicine products, and their PuraPly antimicrobial product line.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $115.18m | $109.41m | - | $471000.0 | 0.00% | 0.43% |
| June 30, 2024 | $130.23m | $144.75m | - | $620000.0 | 0.00% | 0.43% |
| March 31, 2024 | $109.98m | $114.34m | - | $514000.0 | 0.00% | 0.45% |
Company Impact
Help us evaluate Organogenesis Holdings Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.